HuagongsheHuagongshe Chemistry Print Report · For research reference only
(R)-3-methylisothiazolidine 1,1-dioxide → (R)-[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl][2-methyl-4-(3-methyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl]methanone
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | (R)-3-methylisothiazolidine 1,1-dioxide | HCID 16664802 | — |
| Reactant | [4-(3,5-Dimethylpyridin-2-yl)piperazin-1-yl](4-iodo-2-methylphenyl)methanone | HCID 71252193 | — |
| Product | (R)-[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl][2-methyl-4-(3-methyl-1,1-dioxo-1lambda6-isothiazolidin-2-yl)phenyl]methanone | HCID 71252472 | 51.8% |
Reaction Steps
Using [4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl](4-iodo-2-methylphenyl)methanone (562 mg) described in Preparation Example 154 and (R)-3-methylisothiazolidine 1,1-dioxide (175 mg) described in Preparation Example 2 and by the reaction and treatment in the same manner as in Example 1, the title compound (296 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08816079B2 |
| Source dataset | uspto-grants-2014_08 |
| ORD ID | ord-cabad59a9483457c9ff92f8bcc6a7b61 |
| Source note | uspto-grants-2014_08 |